The Supreme Court on Friday issued notice to Centre and Ranbaxy Laboratories Ltd on a PIL seeking cancellation of the company's license and a CBI probe against it for allegedly supplying adulterated drugs in the country.A Bench headed by Chief Justice P Sathasivam, however, refused to pass any interim order for restraining the company from manufacturing drugs.The PIL was filed by advocate M...